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OBJECTIVES: Hypertonic saline has been proposed to modulate the inflammatory cascade in certain
experimental conditions, including pulmonary inflammation caused by inhaled gastric contents. The present
study aimed to assess the potential anti-inflammatory effects of administering a single intravenous dose of
7.5% hypertonic saline in an experimental model of acute lung injury induced by hydrochloric acid.
METHODS: Thirty-two pigs were anesthetized and randomly allocated into the following four groups: Sham,
which received anesthesia and were observed; HS, which received intravenous 7.5% hypertonic saline solution
(4 ml/kg); acute lung injury, which were subjected to acute lung injury with intratracheal hydrochloric acid; and
acute lung injury + hypertonic saline, which were subjected to acute lung injury with hydrochloric acid and
treated with hypertonic saline. Hemodynamic and ventilatory parameters were recorded over four hours.
Subsequently, bronchoalveolar lavage samples were collected at the end of the observation period to measure
cytokine levels using an oxidative burst analysis, and lung tissue was collected for a histological analysis.
RESULTS: Hydrochloric acid instillation caused marked changes in respiratory mechanics as well as blood gas and
lung parenchyma parameters. Despite the absence of a significant difference between the acute lung injury and
acute lung injury + hypertonic saline groups, the acute lung injury animals presented higher neutrophil and
tumor necrosis factor alpha (TNF-a), interleukin (IL)-6 and IL-8 levels in the bronchoalveolar lavage analysis. The
histopathological analysis revealed pulmonary edema, congestion and alveolar collapse in both groups;
however, the differences between groups were not significant. Despite the lower cytokine and neutrophil levels
observed in the acute lung injury+ hypertonic saline group, significant differences were not observed among
the treated and non-treated groups.
CONCLUSIONS: Hypertonic saline infusion after intratracheal hydrochloric acid instillation does not have an
effect on inflammatory biomarkers or respiratory gas exchange.
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’ INTRODUCTION
The aspiration of acid gastric contents is the second most
common cause of direct acute lung injury (ALI) (1), and it
accounts for 10% of all acute respiratory distress syndrome
(ARDS) cases (2). Pulmonary inhalation of gastric contents
may provoke ALI with different degrees of respiratory
compromise and is frequently observed among patients
who have depressed airway protective reflexes, such as
traumatized patients (3,4). In addition to the potential risk
of developing ARDS (5), the inhalation of gastric contents
is a common cause of donor lung rejection (6).
Hyperosmolar solutions, such as hypertonic saline, have been
tested in an attempt to reduce inflammation in ALI (7-9).
However, previous results are contradictory and indicate that
the effects of hypertonic saline depend on the type and agent of
lung injury and timing of administration (10,11).
The ALI model used in the current study involves the
intratracheal instillation of hydrochloric acid (HCl) and
attempts to mimic the clinical scenario of gastric content
aspiration, wherein a pulmonary lesion is caused by the actionDOI: 10.6061/clinics/2015(08)08
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of HCl. The acid causes chemical lesions in the lungs, resulting
in diffuse injury to the alveoli, release of inflammatory
mediators, recruitment of polymorphonuclear cells and promo-
tion of severe edema, and these complications cause a
significant reduction in pulmonary compliance and compro-
mise gas exchange (12-14). We hypothesized that hypertonic
saline would modulate HCl-induced lung injury. The purpose
of this investigation was to test whether a 7.5% hypertonic
saline dose could attenuate the inflammatory response evoked
by HCl instillation.
’ METHODS
This study was approved by the Ethics and Animal
Investigation Committee of the affiliated institution (CAPPesq
0363/08) and was performed in accordance with the Guide for
the Care and Use of Laboratory Animals (15). Thirty-two
young female Landrace pigs weighing between 27 and 33 kg
(29±2.9) were included in this study. Animals were submitted
to 12-hour fasting with free access to water, pre-medicated
intramuscularly with ketamine (5 mg/kg) and midazolam
(0.5 mg/kg), and catheterized using a marginal ear vein for
drug and fluid administration. After sedation, the animals were
anesthetized with an intravenous dose of propofol (3-5 mg/
kg), orally intubated (6.5 mm internal diameter cuffed endo-
tracheal tube) and placed in the supine position. The lungs
were mechanically ventilated (Primus, Dräger, Germany) using
pressure-controlled ventilation (FiO2 50%, tidal volume of
8 ml/kg, inspiratory:expiratory (I:E) of 1:2 and positive end-
expiratory pressure (PEEP) of 5 cmH2O), with the respira-
tory frequency adjusted to maintain end-tidal CO2 between
35 and 40 mmHg. To achieve patient-ventilator synchrony,
pancuronium bromide (0.3 mg/kg/h) was administered
through continuous venous infusion. Anesthesia was main-
tained with 1.5% isoflurane administered through a cali-
brated vaporizer (Vapor 2000, Draeger, Lubeck, Germany).
The body temperature was maintained between 37 ˚C and
38 ˚C using a circulating water mattress.
Monitoring
An arterial catheter was inserted into the right femoral
artery, and a 7.5 French pulmonary artery catheter that
measured continuous cardiac output (Edwards Lifesciences
Corp., Irvine, CA) was inserted into the right jugular vein.
The heart rate (HR), mean arterial pressure (MAP), mean
pulmonary artery pressure (MPAP), pulmonary artery
wedge pressure (PAWP) and central venous pressure (CVP)
were obtained directly using a multiparametric monitor
(IntelliVue MP40, Phillips, Böblinger, Germany). Using
conventional formulae, following indexes were derived:
cardiac index (CI), pulmonary vascular resistance index
(PVRI) and systemic vascular resistance index (SVRI).
The inspiratory peak pressure, plateau inspiratory pres-
sure, static pulmonary compliance, respiratory frequency
and tidal volume were obtained directly from the ventilator
monitor. Arterial blood samples were collected at each time
point and were immediately analyzed (ABL 555; Radiometer,
Copenhagen, Denmark), and the PaO2/FiO2 ratio was
calculated.
Study design
After preparation, all of the animals were submitted to
three series of recruitment maneuvers consisting of 30 s of
sustained inflation with 20 cmH2O pressure followed by 30 s
of regular ventilation. The animals were allowed to stabilize
for 30 min and then randomly assigned to four groups: Sham
(n=8), hypertonic saline (HS; n=8), acute lung injury (ALI;
n=8) and acute lung injury + hypertonic saline (ALI+HS;
n=8). ALI was induced in the ALI and ALI+HS groups via
intratracheal instillation of HCl through the distal port of a
bronchoscope. The ALI+HS animals were treated with 7.5%
hypertonic saline (4 mg/kg) 15 min after HCl instillation.
The Sham and HS groups served as controls. The animals
from the HS group were administered 7.5% hypertonic saline
(4 ml/kg) 15 min after the baseline measurement.
The experimental protocol is outlined in Figure 1.
Collecting points
Following a 30-min stabilization period, baseline (BL)
measurements were performed. ALI was induced immedi-
ately after BL measurements in the ALI and ALI+HS
groups. A new series of measurements was collected 30 min
after the administration of HCl (T30) and hourly thereafter
(T90, T150, T210, T270).
Blood samples were collected at the above time points, and
bronchoalveolar lavage (BAL) sampling was performed with
3 x 20 ml phosphate buffered saline (PBS) at T270 through
bronchoscopy of the upper right lobe of the lung.
ALI induced by HCl
A 0.1 N HCl pH 1.0 solution was prepared by the
hospital’s pharmacy department and instilled at a dose of
4 ml/kg body weight at the level of the carina over a 4 min
period through a bronchoscope (Pentax FB-15H, Montvale,
NJ). ALI was established when the PaO2/FiO2 ratio fell
below 300 mmHg, which was achieved approximately 10
min after hydrochloric acid inhalation.
Figure 1 - Study design.
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Neutrophil count and oxidative burst analysis
The BAL samples were pooled, and a 0.2 ml aliquot was
transferred to an Eppendorf tube, stained with 0.2% trypan
blue solution and counted using a Neubauer chamber.
As previously described (16,17), oxidative burst analysis
was performed using a flow cytometer (Becton Dickinson
Immunocytometry System, San Jose, CA, USA) connected to
a computer (Apple, Fremont, CA, USA). BAL cells (2 x 105
cell) were incubated in a 37 ˚C shaking water bath for 30 min
with 200 ml of dichloro-dihydro-fluorescein diacetate
(DCFH-DA; 0.3 mM, Molecular Probes, Invitrogen, Carlsbad,
CA, USA), 200 ml of DCFH-DA and 100 ml of phorbol-12-
myristate-13-acetate (PMA; 1 ng/1 ml, Calbiochem, Gibbs-
town, NJ, USA). In total, 10,000 cellular events were
analyzed by Cell Quest Software, and the results were
expressed as the geometric mean fluorescence intensity
(GMFI).
Cytokine measurements
BAL samples (10 ml) were centrifuged (2,000 rpm, 10 min,
4 ˚C), and the supernatant was stored at -80 ˚C for subsequent
analysis. BAL cytokine levels (interleukin (IL)-1, IL-8, IL-10, and
tumor necrosis factor alpha (TNF-a)) were assessed using
commercially available immunoenzymatic assay (ELISA) kits
containing pig-specific monoclonal antibodies, according to the
manufacturers’ instructions (R&D Systems, Minneapolis, MN,
USA). The obtained concentrations were transformed into
pg/ml values using a nonlinear regression curve.
Lung histology
At the end of the study, the trachea was clamped at the end of
the inspiratory cycle, and the animal’s thorax was opened. Four
samples were collected from the middle area of the left apical
(West’s zone 2) and diaphragmatic lung lobes as well as from
the middle of the right apical and diaphragmatic lung lobes. The
samples were fixed in a 10% formaldehyde solution for
subsequent histologic analysis. The tissue samples were
embedded in paraffin, and 5 mm histological sections were
stained with hematoxylin and eosin. Two pathologists who
were blinded to the study groups performed the histological
analyses simultaneously. Examinations included testing for the
presence of edema, intra-alveolar and interstitial hemorrhages
and polymorphonuclear and mononuclear cell infiltration.
Each assessed histological characteristic was attributed a
score from 0 to 3 according to the level observed in the tissue
(absent (0), mild (1), moderate (2) or severe (3)). The final score
for the animal was determined according to the sum of the
scores from each lobe (maximum score 12).
Table 1 - Hemodynamics and respiratory variables in the control (SHAM and hypertonic saline) and acid lesion (acute lung injury and
acute lung injury + hypertonic saline) groups.
Variable Group BL T30 T90 T150 T210 T270
CI (L/min/m2) SHAM 3.6±0.6 3.7±0.5 4.0±0.5 4.3±0.5 4.3±0.7 4.3±0.7
HS 3.7±0.3 4.1±0.4 4.9±0.4*w 4.9±0.6* 4.6±0.7* 4.5±0.7*
ALI 3.9±0.6 4.2±0.9 4.4±0.9 4.4±0.8 4.2±0.7 4.2±0.5
ALI+HS 3.5±0.3 4.3±0.4* 4.8±0.5* 4.8±0.4* 4.8±0.4* 4.6±0.5*
HR (bpm) SHAM 94±8 97±11 101±19 104±15 107±21 108±28
HS 104±15 105±11 115±15 129±18 122±18 117±10
ALI 106±13 124±15 112±19 122±31 119±30 119±21
ALI+HS 92±12 114±13 120±21 121±12 124±17 121±19
MAP (mmHg) SHAM 54±7 59±6* 69±10* 66±12* 61±9* 61±8*
HS 67±3 72±4* 84±10* 81±12* 76±9* 77±7*
ALI 70±8 80±16* 80±8* 84±9* 82±8* 81±5*
ALI+HS 66±3 83±17* 83±11* 85±11* 85±12* 82±8*
MPAP (mmHg) SHAM 14±2 16±2 15±3 15±3 16±3 15±2
HS 16±2 16±1 19±1* 16±6 18±2** 19±2*
ALI 16±2 25±3*w# 19±3*w# 22±3*w# 21±3*w# 22±4*w#
ALI+HS 14±3 26±5*w# 21±3*w# 24±3*w# 24±4*w# 23±3*w#
CVP (mmHg) SHAM 9±3 11±2 10±3 10±3* 10±2* 10±2
HS 10±2 11±1 11±1 10±1* 10±2* 10±2
ALI 10±1 9±1 10±1 10±1* 10±1* 10±1
ALI+HS 9±1 11±1 9±1 10±1* 10±1* 10±1
PVRI (dyne.sec.cm5.m2) SHAM 131±20 129±18 121±16 131±30 132±28 131±30
HS 128±15 119±30 130±40 130±27 132±31 149±28*
ALI 152±31 331±114*w# 225±51*w# 266±77*w# 230±58*w# 290±51*w#
ALI+HS 137±35 364±127*w# 207±57*w# 266±53*w# 266±66*w# 263±58*w#
SVRI (dyne.sec.cm 5.m2) SHAM 1317±188 1249±138 1348±158 1302±236 1362±202 1274±111
HS 1185±124 1178±140 1157±202 1115±200 1116±228 1172±272
ALI 1228±152 1343±335 1317±354 1372±320 1419±352 1375±187
ALI+HS 1266±175 1349±291 1222±254 1247±280 1251±274 1241±269
PPlat (cmH2O) SHAM 13±1 14±1* 14±1.7* 14±1.6* 14±1.6* 14±1.6*
HS 14±1 14±1,8 14±1.8* 15±1.6* 15±1.9* 15±2*
ALI 14±1 23±1.3*w# 21±1.5*w# 21±1.7*w# 21±1.8*w# 21±1.7*w#
ALI+HS 14±1 23±1.6*w# 21±1.7*w# 21±1.6*w# 21±1.2*w# 21±1.2*w#
Compl (cmH2O) SHAM 31±4.1 30±4.5 29±4 29±4.3* 28±4* 28±3.6*
HS 29±4.5 28±4.6 26±3.8* 26±3.8* 25±4.4* 24±4.3*
ALI 28±4.2 14±1.4*w# 16±2*w# 16±1.9*w# 16±1.5*w# 16±2.5*w#
ALI+HS 28±4.2 13±2*w# 15±1.6*w# 15±1.7*w# 15±1.7*w# 15±2*w#
Data are expressed as the mean±standard deviation. CI: cardiac index; HR: heart rate; MAP: mean arterial pressure; MPAP: mean pulmonary arterial
pressure; CVP: central venous pressure; PVRI: pulmonary vascular resistance index; SVRI: systemic vascular resistance index; PPlat: plateau pressure; Compl:
pulmonary compliance; *po0.05 compared with the baseline; wpo0.01 compared with the Sham group; # po0.05 compared with the HS group.
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Statistical analysis
The results were expressed as the mean±standard
deviation (SD). Statistical analyses were performed using a
repeated measures analysis of variance (ANOVA) followed
by Tukey’s test to analyze the group effect on the investigated
parameters. A one-way ANOVA was used to analyze the
histopathological results. Significance was established at the
level of 5% (po0.05).
’ RESULTS
The body weights of the animals did not differ between
groups. In addition, the administered amount of infused
7.5% hypertonic saline (HS: 171±16 ml; ALI+HS: 112±11 ml)
and HCl (ALI: 119±12 ml; ALI + HS: 112±12 ml) were also
similar among the groups.
Hemodynamic and respiratory data
The hemodynamic measurements were similar for each of
the investigated groups throughout the period of observa-
tion, and significant changes were not observed in the MAP,
CVP, or SVRI values. However, the pulmonary arterial
pressure and PVRI values exhibited significant increases
after T30 and remained high throughout the observation
period in the ALI and ALI+HS groups (Table 1). Following
HCl instillation, both lung injury groups exhibited significant
reductions in static pulmonary compliance and increases in
Pplat (plateau pressure). The PaO2/FiO2 ratio exhibited a
significant reduction at T30 in injured animals, or those in the
ALI and ALI+HS groups (240±40 and 244±51, respec-
tively, po0.001), compared with those in the control animals,
or the Sham and HS groups (467±37 and 445±57,
respectively), and this ratio remained low throughout the
observation period (Figure 2).
BAL cytokines, neutrophil count and oxidative
burst analysis
ALI animals showed higher TNF and IL-8 levels relative to
the Sham, HS and ALI+HS groups. Higher levels of IL-1B
were found in the ALI+HS group, followed by the ALI group
(Figure 3).
The ALI and ALI+HS groups (34.4±3.5 and 30.2±7.7
neutrophils x 103/ml, respectively) presented higher BAL
neutrophil counts relative to the Sham and HS groups
(18.7±1.6 and 17.9±1.5 neutrophils x 103/ml, respectively).
Additionally, the ALI and ALI+HS groups presented
significantly higher activity (244.8±130 and 232.6±122
GMFI, respectively) in BAL neutrophils in the PMA-induced
burst responses compared with that of the Sham and HS
groups (51.7±22 and 57±20.2 GMFI, respectively).
Histological analysis
The score for histological injury was significantly higher in
the ALI and ALI+HS groups compared with the Sham and
HS groups (Figure 4).
The pattern of lung injury observed in the ALI and ALI+
HS groups was heterogeneous and more evident in the
diaphragmatic lobes. Examination of these lung tissues
revealed large areas of alveolar architecture destruction,
hemorrhage, edema and inflammatory polymorphonuclear
and mononuclear cell infiltration (Figure 5). However,
significant differences were not observed between the scores
exhibited by animals in the ALI and ALI+HS groups.
’ DISCUSSION
In the present study, we demonstrated that hypertonic
saline infused after intratracheal HCl instillation attenuated
increases in BAL neutrophil counts and inflammatory
cytokine concentrations. HCl instillation alone induced a
severe direct lung injury as evidenced by an intense
inflammatory reaction observed in the lung histology, BAL
cytokine levels and oxidative burst. Lung function was also
adversely affected, which was indicated by decreased gas
exchange and reduced lung compliance.
Previous studies have attributed beneficial effects to hyper-
tonic saline in a number of ALI models, such as oleic acid and
ischemia/reperfusion-induced lung injury (7,18,19). The use of
hypertonic saline solution has also demonstrated potential anti-
inflammatory effects related to neutrophil activation (20) in cell
cultures as well as in experimental models of sepsis and
hemorrhagic shock (21-23). Hypertonic saline solution acts on
polymorphonuclear A2 adenosine receptors and causes a
feedback mechanism that stimulates cAMP and PKA release,
thus blocking neutrophil activation (21-23).
It is believed that hyperosmolar solutions can also
decrease pulmonary vascular permeability and leukocyte
adhesion molecule expression, especially P-selectin and
L-selectin. This expression hinders neutrophil adhesion to the
endothelium and may result in reduced lung injury (24,25).
Contrary to the results obtained in studies performed in a
HCl-induced lung injury model (8) and an experimental oleic
acid-induced lung injury model (7), which demonstrated that
pulmonary edema decreased in rats treated with 7.5%
hypertonic saline, our histopathological results did not show
a significant differences between the ALI and ALI+HS
groups with regard to the investigated parameters. However,
the ALI+HS group tended to show lower histopathological
scores relative to the ALI group, although this difference was
not significant. Regarding the control groups, significant
differences were not observed between the HS and Sham
groups, which demonstrates that the administration of 7.5%
Figure 2 - Changes in the PaO2/FiO2 ratio in the control (Sham
and HS) and acid-lesion (acute lung injury and AI + hypertonic
saline) groups. *: po0.05 compared with TB; w: po0.05
compared with the Sham group; #: po0.05 compared with the
hypertonic saline group.
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hypertonic saline as an isolated agent did not result in
worsening lung injury scores.
Alveolar-capillary barrier destruction and increased micro-
vascular permeability are known to trigger the process of
lung injury via acid aspiration, which leads to the activation
of leukocytes and their migration to pulmonary tissue as well
as the production of numerous inflammatory mediators (26).
Therefore, our findings of alveolar and interstitial edema and
polymorphonuclear and mononuclear cells sequestration in
response to injury are consistent with the data reported in the
literature.
Although significant differences were not observed
between the ALI and ALI+HS groups, higher concentrations
of TNF-a and IL-8 in the ALI-group BAL were observed.
Figure 3 - Bronchoalveolar lavage cytokines. The values are expressed in pg/ml. Data are presented as the group mean±SD. w: po0.05
compared with the Sham group; #: po0.05 compared with the hypertonic saline group; y: po0.05 compared with the acute lung injury group.
Figure 4 - Scores for histological injury of the lungs. w: po0.05 compared with the Sham group; #: po0.05 compared with the
hypertonic saline group.
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The concentration of IL-10, an anti-inflammatory cytokine,
was significantly lower in the ALI-HS group, which may
have been caused by the lower TNF-a values in this group
because IL-10 expression is closely related to TNF-a
expression (27). However, BAL samples were collected
270 min after acid administration, and the IL-10 concentra-
tion may subsequently increase.
The observed increases in MPAP and PVRI suggest that
pulmonary hypertension occurred as a result of the initial
lung injury triggered by HCl. The two main causes were
chemical injury, which led to the destruction of the alveolar-
capillary barrier and an increase of pulmonary permeability
(28), and pulmonary blood flow redistribution triggered by a
physiological process known as hypoxic pulmonary vaso-
constriction (HPV), which optimizes the ventilation/perfu-
sion ratio and blood oxygenation by gas exchange.
Regarding the gas exchange, we also found a statistically
significant decrease in the PaO2/FiO2 ratio, which was
approximately 50% lower in the ALI and ALI+HS groups
compared with the other groups. This finding is consistent
with the results obtained by Inci et al. (29) in rats after HCl
instillation. The PaO2 values, however, were only signifi-
cantly different among the injury and control groups at the
T30 time point and returned to BL values at subsequent time
points. Although the PaO2/FiO2 ratio gradually increased
throughout the study, these values remained lower in the
treated groups compared with the non-injured groups.
Although the PaO2 value and PaO2/FiO2 ratio gradually
increased over the observation period, a similar response was
not observed in pulmonary compliance, which remained lower
for the duration of the study. Vascular occlusion and hypoxic
vasoconstriction may shift blood from non-aerated to aerated
lung areas, thus contributing to oxygenation improvement.
In addition, to minimize secondary lung injury caused by
the ventilator, we limited the pressure-controlled ventilation
to a volume of 8 ml/kg and 5 cmH2O PEEP. We also
maintained Pplat values below 30 cmH2O throughout the
study, which is similar to the standard defined for patients
with ARDS [30]. We observed a significant Pplat increase in
animals after HCl instillation, which was positively corre-
lated with increases in the mPAP and PVRI values. More-
over, the ALI and ALI+HS groups also showed significantly
reduced pulmonary compliance after HCl instillation com-
pared with the control groups. These changes in ventilatory
parameters remained throughout the study period and
corroborate the results of other studies using HCl- or oleic
acid-induced lung injury (29,31).
This ALI model was capable of inducing increased
changes in ventilatory parameters, and it also induced the
release of inflammatory cytokines in the bronchoalveolar
lavage samples in the ALI and ALI+HS groups. The
histopathological analysis identified areas of heterogeneous
injury characterized by polymorphonuclear infiltrates, alveo-
lar hemorrhage, and edema in the groups subjected to ALI.
Although the use of 7.5% hypertonic saline was shown to
be safe in our study, the benefits of its use remain uncertain
because we did not observe improvements in any of the
investigated parameters among animals in the injury group.
Figure 5 - Representative photomicrographs with hematoxylin and eosin (H&E) staining (x200) of the lungs of pigs submitted to acute
lung injury. A) Sham group. B) hypertonic saline group. C) acute lung injury group. D) acute lung injury + hypertonic saline group.
Extensive alveolar and interstitial inflammatory infiltration was seen in both injury groups.
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